NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NIDDK E-063-2012-0-US-02 Personalized Dynamic Feedback Control Of Body Weight US ORD 13/754,058 9569483 Issued PDF
NCCIH E-148-2010-0-US-07 Treatment of Metabolic Syndrome and Insulin Resistance with Citrus Flavones US National Stage 13/813,072 Abandoned
NCI E-070-2013-0-US-01 Microfabricated Polymeric Silicone Hydrogel Vessel Mimetics US 61/758,198 Abandoned
NICHD E-001-2007-0-US-07 Conjugates of Plasmodium Falciparum Surface Proteins as Malaria Vaccines US DIV 13/750,495 8900599 Abandoned PDF
NIDDK E-073-2012-0-US-02 Fluorescent Antagonists Of The A3 Adenosine Receptor US ORD 13/748,826 9227979 Abandoned PDF
NIMH E-245-2006-1-PCT-02 Schizophrenia-Related Isoform of KCNH2 and Development of Antipsychotic Drugs PCT PCT PCT/US13/22878 Expired
NIMH E-245-2006-1-EP-03 Schizophrenia-Related Isoform of KCNH2 and Development of Antipsychotic Drugs EP National Stage 13702565.6 Abandoned
NICHD E-068-2012-0-US-02 Device For Simulating Explosive Blast And Imaging Biological Specimen US ORD 13/748,410 9217698 Issued PDF
NCI E-020-2013-0-US-01 Compositions and Methods for Detecting Neoplasia US 61/755,891 Abandoned
NIAID E-172-2007-2-US-03 Aegyptin And Uses Thereof US CON 13/746,631 8980859 Issued PDF
NIAID E-184-2010-1-US-01 Method Of Preventing Or Treating Viral Infection US CIP 13/747,406 8871789 Abandoned PDF
NCI E-300-2001-0-US-06 New Tumor Suppressor Gene, p28ING5 US DIV 13/747,282 Abandoned
NIA E-049-2001-0-JP-22 GLP-1 Exendin-4 Peptide Analogs and Uses Thereof JP DIV 2013-007734 Expired
NCATS E-294-2009-0-US-04 Use Of Delta-tocopherol For The Treatment Of Lysosomal Storage Disorders US National Stage 13/810,774 9044451 Issued PDF
NCATS E-074-2012-0-IN-07 Organic Compounds IN National Stage 6580/DELNP/2014 Issued
NCATS E-074-2012-0-CA-04 Organic Compounds CA National Stage 2861350 Issued
NCATS E-074-2012-0-DK-12 Organic Compounds DK EP 13738252.9 Issued
NCATS E-074-2012-0-BE-09 Organic Compounds BE EP 13738252.9 Issued
NCATS E-074-2012-0-EP-06 Organic Compounds EP National Stage 13738252.9 Issued
NCATS E-074-2012-0-ES-13 Organic Compounds ES EP 13738252.9 Issued
NCATS E-074-2012-0-SE-20 Organic Compounds SE EP 13738252.9 Issued
NCATS E-074-2012-0-NO-19 Organic Compounds NO EP 13738252.9 Issued
NCATS E-074-2012-0-IT-16 Organic Compounds IT EP 13738252.9 Issued
NCATS E-074-2012-0-FR-14 Organic Compounds FR EP 13738252.9 Issued
NCATS E-074-2012-0-DE-11 Organic Compounds DE EP 13738252.9 Issued
NCATS E-074-2012-0-LU-17 Organic Compounds LU EP 13738252.9 Issued
NCATS E-074-2012-0-NL-18 Organic Compounds NL EP 13738252.9 Issued
NCATS E-074-2012-0-CH-10 Organic Compounds CH EP 13738252.9 Issued
NCATS E-074-2012-0-GB-15 Organic Compounds GB EP 13738252.9 Issued
NCATS E-074-2012-0-AU-03 Organic Compounds AU National Stage 2013209884 Issued
NCATS E-074-2012-0-CN-05 Organic Compounds CN National Stage 201380010564.7 Issued
NCI E-273-2009-0-US-03 Adoptive Cell Therapy With Young T Cells US DIV 13/742,541 9074185 Issued PDF
NIAID E-145-2004-3-US-04 Monoclonal Antibodies Against Orthopoxviruses US DIV 13/742,480 8999336 Issued PDF
NCATS E-074-2012-0-PCT-02 Organic Compounds PCT PCT PCT/US2013/021749 Expired
NIAID E-133-2012-0-US-01 Novel Attenuated Vaccine US 61/753,320 Abandoned
NCATS E-298-2011-1-US-01 Activators Of Human Pyruvate Kinase US 61/752,698 Abandoned
NCI E-103-2010-1-US-03 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins. US National Stage 13/699,535 8911728 Issued PDF
NIDA E-234-2005-1-US-05 Benztropine Compounds And Uses Thereof US DIV 13/739,724 Abandoned
NCI E-167-1997-0-JP-26 The Use of Nitroxide or a Prodrug Thereof In The Prophylactic And Therapeutic Treatment of Cancer JP DIV 003496/2013 Abandoned
NINDS E-133-2006-1-JP-13 Compounds For The Treatment Of Spinal Muscular Atrophy And Other Uses JP DIV 004082/2013 Abandoned
NIA E-078-2008-0-US-01 Empty Viral Particle-Based Safe Immunotherapeutics For Treatment Of Alzheimer's Disease US 61/751,769 Abandoned
NCI E-029-2006-1-JP-12 Novel Indenoisoquinoline Derivatives As Anti-proliferative Agents In Cancer Treatment JP DIV 2013-002845 Issued
NIAID E-019-2007-2-JP-14 Influenza Hemagglutinin and Neuramindase Variants JP DIV 2013000771 Abandoned
NCI E-233-2004-0-US-11 Live Microbial Microbicides US DIV 13/735,638 Abandoned
NHLBI E-207-2011-1-PCT-01 Multilayer-coated Micro Grating Array For X-ray Phase Sensitive and Scattering Sensitive Imaging PCT PCT PCT/US13/020561 Expired
NCI E-001-2012-0-CA-04 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen CA National Stage 2860599 Issued
NCI E-001-2012-0-JP-07 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen JP National Stage 551304/2014 Issued
NCI E-001-2012-0-NL-16 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen NL EP 13700352.1 Issued
NCI E-001-2012-0-BE-08 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen BE EP 13700352.1 Issued
NCI E-001-2012-0-GB-14 Native and Agonist CTL Epitopes of The MUC1 Tumor Antigen GB EP 13700352.1 Issued